Начало › Рак на белия дроб с недребноклетъчен тип › Ню Джърси › Edison
Клинични проучвания за Рак на белия дроб с недребноклетъчен тип в Edison, NJ
47 проучвания за Рак на белия дроб с недребноклетъчен тип търсят участници в обекти в и около Edison (в радиус от около 30 мили). Отворете проучването, за да видите кой може да участва и как да се свържете с екипа.
Официален текст на проучването (английски)
Търсите участници за проучване? Представяме го в началото на тази страница — $99 за 30 дни →
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Набиране на участнициФаза 2
- Astera Cancer Care /ID# 272359, East Brunswick · на 6 мили
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Набиране на участнициФаза 2/3
- Astera Cancer Care /ID# 277570, East Brunswick · на 6 мили
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
Набиране на участнициФаза 1/2
- Astera Cancer Care /ID# 271915, East Brunswick · на 6 мили
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Набиране на участнициФаза 1
- START New Jersey, East Brunswick · на 6 мили
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
Набиране на участнициФаза 2
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · на 15 мили
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Набиране на участнициФаза 1
- Exelixis Clinical Site #88, East Brunswick · на 6 мили
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer
Набиране на участнициФаза 2
- START New Jersey, East Brunswick · на 6 мили
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
Набиране на участнициФаза 1
- Research Site, New Brunswick · на 3 мили
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
Набиране на участнициФаза 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · на 3 мили
A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)
Набиране на участнициФаза 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · на 3 мили
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Набиране на участнициФаза 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · на 3 мили
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Набиране на участнициФаза 2/3
- Astera Cancer Care, East Brunswick · на 6 мили
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Набиране на участнициФаза 1/2
- Rutgers Cancer Institute of New Jersey, New Brunswick · на 3 мили
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Набиране на участнициФаза 3
- Clinical Study Site, New Brunswick · на 3 мили
A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation
Набиране на участнициФаза 3
- Astera Cancer Care, Edison
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Набиране на участнициФаза 2/3
- Local Institution - 007-975-A, Somerset · на 4 мили
- Local Institution - 007-975-B, Somerset · на 4 мили
- Local Institution - 007-975-C, Somerset · на 4 мили
- и още 2
A Study of Tepotinib and Ivonescimab in People With Non-Small Cell Lung Cancer
Набиране на участнициФаза 1
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · на 15 мили
A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease
Набиране на участнициФаза 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · на 15 мили
Using Urine Samples to Identify Lung Cancer
Набиране на участнициНаблюдателно проучванеЗдравите доброволци са добре дошли
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · на 15 мили
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Набиране на участнициНаблюдателно проучване
- Astera Cancer Care, East Brunswick · на 6 мили
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
Набиране на участнициФаза 1/2
- START New Jersey East Brunswick, East Brunswick · на 6 мили
Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers
Набиране на участнициФаза 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · на 15 мили
A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
Набиране на участнициФаза 1
- Site 104 - START New Jersey, East Brunswick · на 6 мили
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Набиране на участнициФаза 1
- Rutgers Cancer Institute, New Brunswick · на 3 мили
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Набиране на участнициФаза 1
- Rutgers Cancer Institute of New Jersey, New Brunswick · на 3 мили
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
Набиране на участнициФаза 1
- Rutgers Cancer Institute of New Jersey, New Brunswick · на 3 мили
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
Набиране на участници
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · на 15 мили
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
Набиране на участнициФаза 2
- Astera Cancer Care, East Brunswick · на 6 мили
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Набиране на участнициФаза 3
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · на 15 мили
Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity
Набиране на участнициФаза 2
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · на 15 мили
A Study of Ivonescimab in Combination With Dato-DXd or Osimertinib in People With Non-Small Cell Lung Cancer
Набиране на участнициФаза 1/2
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · на 15 мили
Extracellular Vesicles and Particles (EVP) as Biomarkers of Recurrence in Non-Small Cell Lung Cancer
Набиране на участнициНаблюдателно проучване
- Memorial Sloan Kettering Basking Ridge (Consent Only), Basking Ridge · на 15 мили
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
Набиране на участнициФаза 1
- START Astera, LLC, East Brunswick · на 6 мили
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
Набиране на участнициФаза 1
- Rutgers Cancer Institute of New Jersey, New Brunswick · на 3 мили
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Набиране на участнициФаза 2
- Virtua Voorhees, Voorhees Township · на 5 мили
A Study of Ivonescimab in People With Non-Small Cell Lung Cancer
Набиране на участнициФаза 1/2
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · на 15 мили
A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)
Набиране на участнициФаза 2
- Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · на 15 мили
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Набиране на участнициФаза 2
- Virtua Voorhees, Voorhees Township · на 5 мили
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Набиране на участнициФаза 2/3
- Virtua Voorhees, Voorhees Township · на 5 мили
Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm
Набиране на участнициФаза 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · на 3 мили
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Набиране на участнициФаза 2
- Virtua Voorhees, Voorhees Township · на 5 мили
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · на 15 мили
A Study of Ivonescimab, Chemotherapy, and Stereotactic Radiosurgery for People With Non-Small Cell Lung Cancer
Набиране на участнициФаза 1/2
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · на 15 мили
Using E-Nose Technology to Track Treatment Response in People With Non-Small Cell Lung Cancer
Набиране на участнициФаза 2
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · на 15 мили
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
Набиране на участнициФаза 2
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · на 15 мили
A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung Cancer
Набиране на участнициФаза 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · на 15 мили
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
Набиране на участнициФаза 1/2
- START, Astera, East Brunswick · на 6 мили
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Набиране на участнициНаблюдателно проучване
- Massive Bio SYNERGY-AI site, New Brunswick · на 3 мили
Проучвания за Рак на белия дроб с недребноклетъчен тип в други градове
- Houston, TX145 проучвания
- New York City, NY121 проучвания
- Arlington, VA104 проучвания
- Nashville, TN97 проучвания
- Boston, MA90 проучвания
- Los Angeles, CA87 проучвания
- St. Louis, MO73 проучвания
- Chicago, IL61 проучвания
- Baltimore, MD60 проучвания
- San Antonio, TX59 проучвания
- Columbus, OH57 проучвания
- Washington, DC55 проучвания
Други проучвания в Edison
- Рак на гърдата68 проучвания
- Рак (всички видове)33 проучвания
- Рак на простатата29 проучвания
- Колоректален рак23 проучвания
- Рак на белия дроб23 проучвания
- Множествен миелом22 проучвания
- Рак на пикочния мехур21 проучвания
- Остра миелоидна левкемия20 проучвания
- Рак на яйчниците20 проучвания
- Метастатичен рак20 проучвания
- Ендометриален рак19 проучвания
- Уротелиен (преходноклетъчен) карцином18 проучвания
От ClinicalTrials.gov, данни към 6.10.2026 г.. Всяко проучване има свои критерии за участие; екипът на проучването определя кой може да се включи.